Editorial Board
Moses Ocan Postdoc (University of California, Berkeley and University of California, San Francisco); Philosophy in Pharmacology (PhD) (Makerere University); PGD (Applied Clinical Research and Evidence Based Medicine) (Infectious Disease Institute, Makerere Universit
Senior Lecturer, Makerere University, Kampala, Kampala · Uganda
Editorial leadership for International Journal of Chemotherapy Research and Practice
Research interests
- Antimicrobial Drug Use
- Community Medicine Use
- Pre-Clinical Studies
- Rational Medicine Use
- Systematic Reviews
- Clinical Pharmacy
- Clinical Pharmacology
Biography
- I am a lecturer at the department of Pharmacology & Therapeutics, Makerere University.
- I hold a PhD in Pharmacology and have been teaching for the past ten years
Selected publications
- Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors 2019 cited 79×
- K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors 2019 cited 44×
- Efficacy of antimalarial herbal medicines used by communities in malaria affected regions globally: a protocol for systematic review and evidence and gap map 2023 cited 10×
- Impact of stigma on the HIV care cascade among older persons living with HIV in sub-Saharan Africa: protocol for a systematic review Recent 2025 cited 4×
- Role and utility of COVID-19 laboratory testing in low-income and middle-income countries: protocol for rapid evidence synthesis 2021 cited 3×
- Brain MRI for the diagnosis of dementia in low- and middle-income countries: a systematic review and meta-analysis protocol of diagnostic utility and imaging findings Recent 2025 cited 2×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJCP for your work?
This journal is guided by Moses Ocan (Senior Lecturer, Makerere University, Kampala, Kampala) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.